268 related articles for article (PubMed ID: 29555239)
1. NLX-112, a highly selective 5-HT
Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
[TBL] [Abstract][Full Text] [Related]
2. NLX-101, a highly selective 5-HT
Depoortère R; Auclair AL; Newman-Tancredi A
Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
[TBL] [Abstract][Full Text] [Related]
4. NLX-112, a highly selective 5-HT
Newman-Tancredi A; Depoortère R; Carilla-Durand E; Tarayre JP; Kleven M; Koek W; Bardin L; Varney MA
Pharmacol Biochem Behav; 2018 Feb; 165():56-62. PubMed ID: 29126856
[TBL] [Abstract][Full Text] [Related]
5. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
Iderberg H; McCreary AC; Varney MA; Kleven MS; Koek W; Bardin L; Depoortère R; Cenci MA; Newman-Tancredi A
Exp Neurol; 2015 Sep; 271():335-50. PubMed ID: 26037043
[TBL] [Abstract][Full Text] [Related]
6. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
Psychopharmacology (Berl); 2012 May; 221(2):261-72. PubMed ID: 22147258
[TBL] [Abstract][Full Text] [Related]
7. Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model.
Depoortère R; Papp M; Gruca P; Lason-Tyburkiewicz M; Niemczyk M; Varney MA; Newman-Tancredi A
J Psychopharmacol; 2019 Nov; 33(11):1456-1466. PubMed ID: 31290370
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
9. The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Jastrzębska-Więsek M; Wesołowska A; Kołaczkowski M; Varney MA; Newman-Tancredi A; Depoortere R
Behav Pharmacol; 2022 Aug; 33(5):333-341. PubMed ID: 35695543
[TBL] [Abstract][Full Text] [Related]
10. Improvement of lower urinary tract function by a selective serotonin 5-HT
Lin CY; Sparks A; Lee YS
Exp Neurol; 2020 Oct; 332():113395. PubMed ID: 32615138
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT
Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
[TBL] [Abstract][Full Text] [Related]
12. 5-HT1A receptor agonist Befiradol reduces fentanyl-induced respiratory depression, analgesia, and sedation in rats.
Ren J; Ding X; Greer JJ
Anesthesiology; 2015 Feb; 122(2):424-34. PubMed ID: 25313880
[TBL] [Abstract][Full Text] [Related]
13. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
[TBL] [Abstract][Full Text] [Related]
14. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study.
Buritova J; Larrue S; Aliaga M; Besson JM; Colpaert F
Eur J Pharmacol; 2005 May; 514(2-3):121-30. PubMed ID: 15910798
[TBL] [Abstract][Full Text] [Related]
15. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
Bardin L; Tarayre JP; Malfetes N; Koek W; Colpaert FC
Pharmacology; 2003 Apr; 67(4):182-94. PubMed ID: 12595749
[TBL] [Abstract][Full Text] [Related]
16. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements.
McCreary AC; Varney MA; Newman-Tancredi A
Neuropharmacology; 2016 Jun; 105():651-660. PubMed ID: 26777281
[TBL] [Abstract][Full Text] [Related]
17. The selective 5-HT
Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
[TBL] [Abstract][Full Text] [Related]
18. The selective 5-HT
Depoortere R; Johnston TH; Fox SH; Brotchie JM; Newman-Tancredi A
Parkinsonism Relat Disord; 2020 Sep; 78():151-157. PubMed ID: 32846366
[TBL] [Abstract][Full Text] [Related]
19. The selective 5-HT
Powell WH; Annett LE; Depoortere R; Newman-Tancredi A; Iravani MM
Naunyn Schmiedebergs Arch Pharmacol; 2022 Feb; 395(2):149-157. PubMed ID: 34821958
[TBL] [Abstract][Full Text] [Related]
20. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
